The First FDA-Cleared Blood Test for Alzheimer’s Diagnosis Now Available on the Market
Neurology
FDA Approves First Blood Test for Alzheimer’s, Marking a Historic Shift in Early Detection
APS2 Blood Test for Alzheimer's Could Revolutionize Early Diagnosis in Primary Care
Tris Pharma Takes Bold Step into Digital Health with AI-Driven ADHD Diagnostic Tool
CAR-T Therapy and Multiple Sclerosis: A New Horizon for Disease Management
Breakthrough in Alzheimer's Diagnosis: APEX Platform Shows Promising Results
Opening Blood-Brain Barrier with Ultrasound to Deliver Alzheimer's Drug
Unraveling the RNA Puzzle in ALS: A Paradigm Shift in Neurodegenerative Research
PARADIGM Trial: PrimeC Demonstrates 37.4% Reduction in ALS Progression
Milestone in Alzheimer's Research: Human Neurons Generated from Stem Cells
Landmark Study Shows Improving Deep Sleep May Protect Against Dementia
Large Genetic Research Promises New Pathways for Migraine Treatment
Promising ABvac40 P2 Results: Araclon's Alzheimer's Vaccine Slows Disease Progression
Discovery of Damaged DNA in the Brain Could Be the Key to Solving Parkinson's Disease
Stanford Study: Stem Cell Therapy Shows Promise in Alzheimer’s Treatment
New Alzheimer’s Drug Candidate, Curbs Inflammation and Enhances Cognition
Approved MS Drug Shows Promise as New Alzheimer’s Therapy
Nightly Aromatherapy Boosts Cognitive Capacity by 226% in the Elderly
DR4 Allele Gene: A New Beacon of Hope Against Alzheimer’s and Parkinson’s
Innovative Blood Test Can Detect Parkinson’s in Its Very Initial Stages
3D Model Research Offers New Treatment Options for Alzheimer's Disease
Bemdaneprocel: Stem Cell Therapy for Parkinson's Shows Promising Results
Smartwatches and AI enable detection of Parkinson's 7 years before symptoms
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
